ANVS Annovis Bio, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $39.5M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $2.7M | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $1.6M | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $5.0M | $0 |
Bought$9.3M9 buy days
Sold$00 sell days
Net insider flow+$9.3Mnet buying · 5 years
Latest trade2026-11-06Hoffman Michael B
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-06 | Buy | Hoffman Michael B | Director | 5,000,000 | $1.00 | $5.0M | 1 |
| 2026-05-20 | Buy | Hoffman Michael B | Director | 76,344 | $1.87 | $142.8K | 3 |
| 2026-04-02 | Buy | Hoffman Michael B | Director | 713,800 | $2.10 | $1.5M | 1 |
| 2025-12-08 | Buy | Hoffman Michael B | Director | 45,000 | $4.31 | $193.8K | 2 |
| 2025-11-24 | Buy | Hoffman Michael B | Director | 39,200 | $4.08 | $159.9K | 4 |
| 2025-11-21 | Buy | Hoffman Michael B | Director | 20,000 | $3.50 | $69.9K | 2 |
| 2025-11-14 | Buy | Hoffman Michael B | Director | 15,000 | $2.11 | $31.6K | 1 |
| 2025-10-28 | Buy | Hoffman Michael B | Director | 975,610 | $2.05 | $2.0M | 1 |
| 2025-10-28 | Buy | Maccecchini Maria-Luisa | CEO | 97,561 | $2.05 | $200.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Hoffman Michael B | Director | $9.1M | $0 | 2026-11-06 |
| Maccecchini Maria-Luisa | CEO | $200.0K | $0 | 2025-10-28 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2021-10-11 → 2021-10-12 | 3 | $639.0K | 59 | -8.5% (-1.9% raw) | -45.2% (-49.7% raw) | -45.9% (-56.9% raw) | closed |
| 2020-01-31 → 2020-02-03 | 6 | $714.2K | 46 | -16.0% (-26.5% raw) | -28.9% (-42.8% raw) | -11.7% (-10.7% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.